{"entity":{"type":"insider","cik":"0001969296","url":"/insider/0001969296","json_url":"/insider/0001969296.json","name":"Cormorant Private Healthcare Fund V LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":4,"first":"2024-10-01","last":"2026-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Cormorant Private Healthcare Fund V LP","source":"filing","n_filings":4,"first_seen":"2024-10-01","last_seen":"2026-08-10"}],"transactions":[{"id":9276040,"accession":"0001231919-26-000852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001231919-26-000852","line_url":"/filing/0001231919-26-000852#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BlossomHill Therapeutics, Inc.","issuer_ticker":"BLSM","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund V LP; Cormorant Private Healthcare Fund VI, LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":3614034.0,"shares_owned_after_display":"3,614,034","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-10","scope":"insider"},{"id":5149439,"accession":"0000929638-25-001950","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-001950","line_url":"/filing/0000929638-25-001950#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813439.0,"shares_display":"1,813,439","price_per_share":1.8545,"price_display":"1.85","price_state":"stated","total_value":3363022.6255,"total_display":"3,363,022.63","total_whole":"3,363,023","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-15","filed_date":"2025-05-19","scope":"insider"},{"id":4574246,"accession":"0000929638-25-001870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000929638-25-001870","line_url":"/filing/0000929638-25-001870#line-1","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"OnKure Therapeutics, Inc.","issuer_ticker":"OKUR","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Global Healthcare Master Fund, LP; Cormorant Private Healthcare Fund III LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24300.0,"shares_display":"24,300","price_per_share":1.985,"price_display":"1.98","price_state":"stated","total_value":48235.5,"total_display":"48,235.50","total_whole":"48,236","shares_owned_after":1813439.0,"shares_owned_after_display":"1,813,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-05-12","filed_date":"2025-05-14","scope":"insider"},{"id":2079689,"accession":"0000929638-24-003363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000929638-24-003363","line_url":"/filing/0000929638-24-003363#line-2","is_derivative":false,"issuer_cik":"0001583977","issuer_name":"BioAge Labs, Inc.","issuer_ticker":"BIOA","issuer_name_source":null,"issuer_url":"/issuer/0001583977","owner_cik":null,"owner_name":"Chen Bihua; Cormorant Asset Management, LP; Cormorant Private Healthcare Fund IV LP; Cormorant Private Healthcare Fund V LP","owner_display_name":"Chen Bihua","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450000.0,"shares_display":"450,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":8100000.0,"total_display":"8,100,000.00","total_whole":"8,100,000","shares_owned_after":1629529.0,"shares_owned_after_display":"1,629,529","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-27","filed_date":"2024-10-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001839970","name":"BlossomHill Therapeutics, Inc.","url":"/issuer/0001839970","role":"Ten percent owner","n_filings":1,"first_seen":"2026-08-10","last_seen":"2026-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"OnKure Therapeutics, Inc.","url":"/issuer/0001637715","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2025-05-14","last_seen":"2025-05-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001709941","name":"BioAge Labs, Inc.","url":"/issuer/0001709941","role":"Other","n_filings":1,"first_seen":"2024-10-01","last_seen":"2024-10-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001969296","retrieved_at":"2026-08-23T00:18:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}